Combination Immunotherapy with Herceptin and the HER2 vaccine E75 in low and intermediate HER2- expressing breast cancer patients to prevent recurrence.

Project: Research project

Project Details

Short titleCombination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
StatusFinished
Effective start/end date1/1/13 → 1/1/18

Funding

  • Galena Biopharma